Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles

Creative Commons License

DERMAN S., MUSTAFAEVA Z. A., ABAMOR E. Ş., BAĞIROVA M., ALLAHVERDİYEV A.

JOURNAL OF BIOMEDICAL SCIENCE, vol.22, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22
  • Publication Date: 2015
  • Doi Number: 10.1186/s12929-015-0195-2
  • Journal Name: JOURNAL OF BIOMEDICAL SCIENCE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Canine Parvovirus, Vaccine, Antigen, Peptide, PLGA, Nanoparticle, Antigen delivery, CO-GLYCOLIC ACID, IMMUNE-RESPONSES, NITRIC-OXIDE, IN-VITRO, DELIVERY-SYSTEMS, VACCINE DELIVERY, DENDRITIC CELLS, CELLULAR UPTAKE, DRUG-DELIVERY, ANTIGEN
  • Yıldız Technical University Affiliated: Yes

Abstract

Background: Canine parvovirus 2 (CPV-2) remains a significant worldwide canine pathogen and the most common cause of viral enteritis in dogs. The 1 L15 and 7 L15 peptides overlap each other with QPDGGQPAV residues (7-15 of VP2 capsid protein of CPV) is shown to produce high immune response. PLGA nanoparticles were demonstrated to have special properties such as; controlled antigen release, protection from degradation, elimination of booster-dose and enhancing the cellular uptake by antigen presenting cells. Nevertheless, there is no study available in literature, about developing vaccine based on PLGA nanoparticles with adjuvant properties against CPV. Thus, the aim of the present study was to synthesize and characterize high immunogenic W-1 L19 peptide (from the VP2 capsid protein of CPV) loaded PLGA nanoparticle and to evaluate their in vitro immunogenic activity.